Patents by Inventor Amara Siva

Amara Siva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8951730
    Abstract: Compositions and reaction mixtures are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and reaction mixtures provide for sensitive and specific detection of the target nucleic acids. The compositions and reaction mixtures include one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and reaction mixtures are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: February 10, 2015
    Assignee: Gen-Probe Incorporated
    Inventors: Amara Siva, Mark A. Reynolds
  • Publication number: 20140205999
    Abstract: Compositions and reaction mixtures are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and reaction mixtures provide for sensitive and specific detection of the target nucleic acids. The compositions and reaction mixtures include one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and reaction mixtures are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.
    Type: Application
    Filed: March 7, 2013
    Publication date: July 24, 2014
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Amara SIVA, Mark A. REYNOLDS
  • Patent number: 8399222
    Abstract: Compositions and methods are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and methods provide for sensitive and specific detection of the target nucleic acids. The compositions and methods include using one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and methods are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: March 19, 2013
    Assignee: Gen-Probe Incorporated
    Inventors: Amara Siva, Mark Alan Reynolds
  • Publication number: 20100129822
    Abstract: Compositions and methods are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and methods provide for sensitive and specific detection of the target nucleic acids. The compositions and methods include using one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and methods are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.
    Type: Application
    Filed: November 25, 2009
    Publication date: May 27, 2010
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Amara SIVA, Mark A. REYNOLDS
  • Publication number: 20080287309
    Abstract: This disclosure relates to methods for selecting antibodies having desirable characteristics from a population of diverse antibodies. More specifically, this disclosure provides methods for identifying antibodies which bind to cancer cells, but which do not bind to human red blood cells, white blood cells or normal tissue cells. Antibodies of the disclosure can be used for therapeutic and/or diagnostic purposes.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 20, 2008
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Katherine S. Bowdish, Hong Xin, Ferda Yantiri-Wernimont, Amara Siva
  • Publication number: 20080008719
    Abstract: The present application relates to methods and compositions for the treatment of cancer. In specific embodiments, the application relates to the use of antibodies capable of modulating CDCP1 as therapeutic agents for the treatment of cancer and as diagnostic agents for the detection of and/or prognosis of cancer.
    Type: Application
    Filed: April 24, 2007
    Publication date: January 10, 2008
    Inventors: Katherine Bowdish, Hong Xin, Ferda Yantiri-Wernimont, Amara Siva